Sociedad Americana de Hirudoterapia

Modified method of multiple cranial burr holes for treatment of total scalp avulsion

Case report published in Neurol India (2020)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportEnsayos clínicosPatil H et al. · Neurology India, 2020

Abstract

Scalp avulsion is a rare but severe injury. It usually happens while using industrial or agriculture machinery. Scalp avulsion results from hair entrapment in a rotating machine. There are various options for treatment of scalp avulsion. Herein, the authors present a case of total scalp avulsion which was treated by multiple trephination technique using neurosurgical burr.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsHairHumansMicrosurgeryReplantationScalpTrephining

Resumen

Total scalp avulsion treated by modified multiple-cranial-burr-holes trephination technique as alternative when microsurgical replantation is not feasible.

Por qué esto importa para la hirudoterapia

This case report presents a single patient with total scalp avulsion that was treated using a multiple trephination technique involving a neurosurgical burr. The abstract focuses entirely on detailing this surgical technique as an option for managing severe scalp avulsion injuries resulting from hair entrapment in machinery. It makes no mention of leech therapy, hirudotherapy, or venous congestion. Consequently, the article has no direct relevance to ASH's domain beyond the broad context of reconstructive surgery, and no leeches were involved in the management of the condition described.

Citación

Modified method of multiple cranial burr holes for treatment of total scalp avulsion.

Patil H et al. · Neurology India, 2020

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.